NMOSD treatment | -- | Terminal complement inhibition
SponsoredEfficacy data, safety and tolerability, dosing schedule, and vaccination requirements. FDA …Weight-based Dosing · Safety · HCP Resources · REMS Program
Complement c5 human | Complement Factor D
SponsoredSEC-MALS verified high purity, ELISA/BLI/SPR verified high biological activity. HEK293 e…HEK293 expressed proteins · High Lots-consistency · 3-5 days global delivery
